Skip to content

Moderna MRNA Ratios & Valuation

Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
Profitability
Gross margin22.1%-32.0pp55.3%+0.6pp48.3%-19.2pp52.5%+19.5pp54.1%+31.7pp
Operating margin-153.3%-36.0pp-158.1%-36.2pp-155.2%-102pp-106.3%-14.4pp-117.4%-17.5pp
Net margin-143.6%-37.9pp-145.2%-35.1pp-139.6%-91.6pp-94.3%+26.2pp-105.7%+14.4pp
Returns
Return on equity-36.6%-7.2pp-28.9%-0.1pp-29.3%-10.1pp-27.5%+15.0pp-29.3%+9.7pp
Return on invested capital-42.5%-7.4pp-35.9%+0.1pp-33.6%-10.9pp-33.8%+3.4pp-35.2%+0.7pp
Efficiency
Asset turnover0.2×0.0×0.1×-0.1×0.2×-0.1×0.2×0.0×0.2×0.0×
Liquidity
Current ratio2.4×-1.8×3.3×-0.4×3.9×-0.5×3.9×-0.2×4.2×+0.2×
Leverage
Debt-to-equity0.2×+0.1×0.2×+0.1×0.1×0.0×0.1×0.0×0.1×0.0×
Per Share
Book value per share$18.75-28.1%$22.24-21.7%$23.92-20.0%$24.22-20.6%$26.08-22.3%
Valuation
Market capitalization$20.15B+83.8%$11.52B-28.0%$10.05B-60.9%$10.36B-77.2%$10.96B-73.1%
Price / sales9.1×+5.6×5.9×+1.0×4.5×-0.6×3.4×-5.6×3.5×-4.5×
Price / book2.7×+1.6×1.3×-0.1×1.1×-1.1×1.1×-2.8×1.1×-2.1×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Moderna's profit margins?
Moderna (MRNA) runs a 22.1% gross margin and a -153.3% operating margin, with a -143.6% net margin.
Where do Moderna's ratios come from?
Every ratio is computed from Moderna's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.